Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artesunate-amodiaquine vs Artemether-lumefantrine for Uncomplicated Malaria in DRC
NCT06076213Phase 4Completed
- Sponsor
- Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Plasmodium falciparum malaria comparing Artesunate-amodiaquine with Artemether-lumefantrine (2 arms). Primary endpoint: PCR adjusted efficacy at Day 28. Started May 2023; status: completed.
02
Drugs
artesunate + amodiaquineartemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT06076213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06076213.